ILMN - イルミナ (Illumina Inc.)

ILMNのニュース

   House Republicans seek information from FTC over Illumina''s Grail takeover  2023/06/08 17:49:06 Seeking Alpha
House Republicans are renewing a call for the Federal Trade Commission to provide it information over its review of Illumina''s planned $7.1 billion takeover of cancer screening test…
   Rocky history of Illumina''s Grail deal  2023/06/06 18:12:21 Investing.com
https://www.investing.com/news/stock-market-news/rocky-history-of-illuminas-grail-deal-3099468
   Apple''s Upcoming VR Headset Marks Significant New Product Debut In Almost 10 Years, Regulators Want Tighter Capital Requirements For Large US Banks, Software Configuration Error at Grail Causes Cancer Misdiagnosis: Today''s Top Stories  2023/06/05 13:45:46 Benzinga
Wall Street Journal Megabanks Beware: Regulatory Big Brother Wants a Tighter Leash Amid Recent Bank Failures U.S. regulators are reportedly gearing up to enforce stricter measures on large banks to enhance their financial stability following a series of failures among midsize banks earlier this year. People familiar with the plans have indicated that the proposed changes could result in an average increase of approximately 20% in overall capital requirements for larger banks. The specific amount will depend on each bank''s business activities, with the most significant increases expected for U.S. megabanks with substantial trading operations. Get Ready For Apple''s WWDC: Software Updates and First New Significant Product In a Decade Apple Inc (NASDAQ: AAPL ) prepares to showcase its VR headset, marking its first significant new product in nearly a decade, on Monday at its annual developer conference. The rest of the conference focuses on software providers making applications in the Apple ecosystem.
   Illumina unit Grail in hot water over erroneous cancer results – FT  2023/06/02 19:38:07 Seeking Alpha
Over 400 patients who opted for early cancer detection tests developed by Illumina (ILMN) subsidiary Grail received erroneous letters last month indicating that they may have…
   Illumina names Hologic CEO as chair, elects Edwards CFO to board  2023/06/02 14:32:37 Seeking Alpha
Illumina''s (ILMN) board has elected Hologic (HOLX) CEO Stephen MacMillan as its new non-executive chair and Edwards Lifesciences (EW) CFO Scott Ullem as an independent director.
   The Market Continues To Underprice Illumina''s Stock And Its Genomics Leadership  2023/06/01 08:54:23 Seeking Alpha
Illumina is undervalued by 23% according to a discounted cash flow analysis, with a fair value of $253.94. Read why ILMN stock is a Buy.
   Illumina CEO survived Icahn’s challenge by more than 2-to-1 margin By Reuters  2023/05/31 01:08:28 Investor Daily Updates
2/2 © Reuters. FILE PHOTO: The offices of gene sequencing company Illumina Inc are shown in San Diego, California January 11, 2016. REUTERS/Mike Blake 2/2 By Svea Herbst-Bayliss NEW YORK (Reuters) – Illumina Inc (NASDAQ:) CEO Francis deSouza survived a challenge to his board seat from activist investor Carl Icahn last week by securing more […] The post Illumina CEO survived Icahn’s challenge by more than 2-to-1 margin By Reuters first appeared on Forex Trader Hub .
   Illumina CEO survived Icahn''s challenge by more than 2-to-1 margin  2023/05/30 22:46:39 Investing.com
https://www.investing.com/news/stock-market-news/illumina-ceo-survived-icahns-challenge-by-more-than-2to1-margin-3094287
   Illumina CEO survived Icahn’s challenge by more than 2-to-1 margin  2023/05/30 22:36:39 Financial Post
NEW YORK — Illumina Inc CEO Francis deSouza survived a challenge to his board seat from activist investor Carl Icahn last week by securing more than twice the shareholder votes than the number his challenger received, the company said in a filing on Tuesday. While the outcome of the vote was known, the tally had […]
   Insider trades & hedge fund moves: Carl Icahn tosses out Illumina chair  2023/05/30 07:42:05 Investing.com
https://www.investing.com/news/stock-market-news/insider-trades--hedge-fund-moves-carl-icahn-tosses-out-illumina-chair-3093037
   Tracking COVID-19 With Dust at the Ohio State University  2022/10/18 17:10:00 Accesswire
NORTHAMPTON, MA / ACCESSWIRE / October 18, 2022 / When COVID-19 hit, most of The Ohio State University-home of the Buckeyes in the state capital of Columbus-shut down. But the Applied Microbiology Services Laboratory (ASML) within its Infectious Diseases Institute (IDI) stayed open. "The Buckeyes are amazing students," says Seth Faith, who serves as the executive director for the Center of Microbiome Science and strategic alliance officer for IDI, but also supervises the lab. "A lot of them are hungry and passionate. At least one individual working in the lab had family in Wuhan, China, and they hadn''t seen their family for two years. They wanted to be a part of solving this pandemic." Over the next two years or so, AMSL employed 88 lab workers at various times, who administered more than 850,000 PCR diagnostic tests for COVID-19, with an average turnaround time of 8.75 hours. Meanwhile, an OSU professor named Karen Dannemiller had been going into homes and businesses looking for toxic chemicals in the built environment.
   Illumina, GenoScreen collaborate on genomic testing for drug-resistant TB  2022/10/18 10:53:32 Seeking Alpha
Illumina (ILMN) and GenoScreen are collaborating to expand access to genomic testing for multidrug-resistant ((MDR)) tuberculosis ((TB)) in an effort to end the disease…
   Illumina and GenoScreen Partner to Expand Access to Genomic Testing for Multidrug-Resistant Tuberculosis  2022/10/18 10:00:00 PR Newswire
Transformative alliance will help advance the World Health Organization''s strategy to end the global TB epidemic by 2035 SAN DIEGO, Oct. 18, 2022 /PRNewswire/ -- Illumina Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, and GenoScreen, an innovative…
   Boosting STEM Education in Bangladesh  2022/10/17 13:10:00 Accesswire
NORTHAMPTON, MA / ACCESSWIRE / October 17, 2022 / Illumina and the Illumina Corporate Foundation have provided a grant to the Child Health Research Foundation (CHRF), a Bangladeshi nonprofit that promotes public health and STEM education. The grant, worth over $300,000, includes cash and in-kind product. The grant will support CHRF''s Building Scientists for Bangladesh program , which will introduce young women in under-resourced communities around the country to science and provide hands-on genomic training for university students and early career professionals. Bangladesh faces a multifaceted problem: Disease burden is high, and access and exposure to STEM education and the benefits and practice of science remain low. To complicate matters further, Bangladeshi universities are experiencing a significant decline in STEM enrollment, particularly among women. CHRF director Senjuti Saha, PhD, and her team hope to counteract this discouraging trend. "We believe that everyone across the world should have equal access to the practice and benefits of science and that if more young women completing high school can see themselves as scientists addressing problems in their communities, they will be encouraged to pursue STEM," says Saha, who is spearheading the education program. "To make science more relatable to their everyday lives-not limited to theories they read about in textbooks-our researchers will take science to high schools across the country, especially in rural communities, and perform easy-to-do experiments to engage students and teachers." The Mission CHRF has been working in Bangladesh since the 1980s because pediatric infections were causing far too many preventable deaths.
   In Our DNA: Suzanne Rohrback, Senior Staff Bioinformatics Scientist at Illumina  2022/10/14 13:45:00 Accesswire
NORTHAMPTON, MA / ACCESSWIRE / October 14, 2022 / Illumina: As a scientist on Illumina''s Assay Research team in San Diego, Suzanne Rohrback works with colleagues to come up with new ways next-generation sequencing (NGS) can maximize insights from a sample-such as cells from a tumor or a tube of blood-extracting as much information about it as possible, as efficiently as possible. Specifically, Rohrback''s role is in bioinformatics; she works closely with her coworkers who perform experiments, turning their hypotheses into code and graphs that build a deep understanding of the system at hand. As she puts it: "I''m a data detective! I''m always asking, ‘What''s different between these samples and why did it change?'' Answering this teaches us how biology works and identifies warning signals that could help doctors and scientists understand, diagnose, or treat disease." Rohrback was an early member of the team that developed the Illumina COVIDSeq™ Test , a high-throughput, sequencing-based, in vitro diagnostic workflow that enables the detection of SARS-CoV-2. "Everything went from zero to 60 in an instant," she says. "I''ve never been so hyper-focused or felt so purposeful and connected to so many coworkers across the globe-many of whom I''d never met.

calendar